Careers  |  Sign In  |  Register

Latest in Oncology

Complementary Blood and Tissue Molecular Testing for Newly Diagnosed NSCLC

Dr. Socinski on Recommendations for Molecular Testing in Lung Cancer

Mark A. Socinski, MD, executive medical director at AdventHealth Cancer Institute, recommends immediate comprehensive molecular testing at the time of lung cancer diagnosis. Stating that oncogenic driver mutation identification is essential to effective targeted therapies, Dr. Socinski suggests complementary...
Hui-Zi Chen, MD, PhD, assistant professor in the Department of Internal Medicine, Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center - James, discusses the future of atezolizumab as a new FDA-approved first-line treatment for metastatic small cell lung cancer. Dr. Chen...

Phase III Cilinical Trials for the Treatment of Metastatic Ocular Melanoma

Dr. Kudchadkar on the Biological Differences Between Ocular and Cutaneous Melanoma

Ragini R. Kudchadkar, MD, associate professor Department of Hematology and Medical Oncology, associate director of Hematology and Medical Oncology Fellowship Program - Clinical/Service at Emory University School of Medicine in the Winship Cancer Institute, discusses treating metastatic ocular melanoma, which...